Back to Journals » OncoTargets and Therapy » Volume 6 » default

OncoTargets and Therapy


Archive: Volume 6, 2013

A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients

Suenaga M, Yamada S, Fujii T, Fuchs BC, Okumura N, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Takeda S, Hayashi K, Tanabe KK, Goto H, Kodera Y

OncoTargets and Therapy 2013, 6:1805-1812

Published Date: 13 December 2013

Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients

Fan Y, Huang Z, Fang L, Miu L, Lin N, Gong L, Yu H, Yang H, Mao W

OncoTargets and Therapy 2013, 6:1789-1803

Published Date: 4 December 2013

Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials

Zhang Y, Sun Y, Wang L, Ye T, Pan Y, Hu H, Yu Y, Zhao N, Song Y, Garfield D, Chen H

OncoTargets and Therapy 2013, 6:1771-1777

Published Date: 29 November 2013

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

Rossi L, Veltri E, Zullo A, Zoratto F, Colonna M, Longo F, Mottolese M, Giannarelli D, Ruco L, Marchetti P, Romiti A, Barucca V, Giannini G, Bianchi L, Tomao S

OncoTargets and Therapy 2013, 6:1761-1769

Published Date: 29 November 2013

Sam68 is a novel marker for aggressive neuroblastoma

Zhao X, Li Z, He B, Liu J, Li S, Zhou L, Pan C, Yu Z, Xu Z

OncoTargets and Therapy 2013, 6:1751-1760

Published Date: 2 December 2013

Signal transduction molecule patterns indicating potential glioblastoma therapy approaches

Cruceru ML, Enciu AM, Popa AC, Albulescu R, Neagu M, Tanase CP, Constantinescu SN

OncoTargets and Therapy 2013, 6:1737-1749

Published Date: 29 November 2013

The potential for targeting extracellular LOX proteins in human malignancy

Mayorca-Guiliani A, Erler JT

OncoTargets and Therapy 2013, 6:1729-1735

Published Date: 25 November 2013

Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma

Tan W, Li Y, Han G, Xu J, Wang X, Li Y, Hu D

OncoTargets and Therapy 2013, 6:1719-1728

Published Date: 21 November 2013

Gemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosis

Jin G, Zhao J, Qi H, Lou M, Liu X, Qu Y, Zhao L, Zhang W, Shao J, Zhong H

OncoTargets and Therapy 2013, 6:1707-1717

Published Date: 25 November 2013

Body mass index and patient CT measurements as a predictor of benefit of intensity-modulated radiotherapy to the supraclavicular fossa

Koh V, Tang JI, Choo BA, Tan CW, Lim BK, Shen L, Lu JJ

OncoTargets and Therapy 2013, 6:1701-1706

Published Date: 21 November 2013

Intraoperative radiotherapy in stage IIB adenocarcinoma of the uterine cervix: a retrospective study

Gao Y, Liu Z, Gao F, Chen X

OncoTargets and Therapy 2013, 6:1695-1700

Published Date: 20 November 2013

Niclosamide suppresses hepatoma cell proliferation via the Wnt pathway

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T

OncoTargets and Therapy 2013, 6:1685-1693

Published Date: 18 November 2013

Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis

Cheng Q, Yi B, Wang A, Jiang X

OncoTargets and Therapy 2013, 6:1675-1684

Published Date: 18 November 2013

B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma

Qin XJ, Zhang HL, Ye DW, Dai B, Zhu Y, Shi GH

OncoTargets and Therapy 2013, 6:1667-1673

Published Date: 15 November 2013

Prognostic factors associated with solitary plasmacytoma

Guo SQ, Zhang L, Wang YF, Sun BC, Zhang LY, Zhang J, Wang GW, Zhang YZ

OncoTargets and Therapy 2013, 6:1659-1666

Published Date: 14 November 2013

Synchronous BRAFV600E and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity

Gadiot J, Hooijkaas AI, Deken MA, Blank CU

OncoTargets and Therapy 2013, 6:1649-1658

Published Date: 28 November 2013

The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells

Chai F, Zhou J, Chen C, Xie S, Chen X, Su P, Shi J

OncoTargets and Therapy 2013, 6:1643-1647

Published Date: 12 November 2013

Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer

Kim JS, Lee SD, Lee SJ, Chung MK

OncoTargets and Therapy 2013, 6:1635-1642

Published Date: 12 November 2013

Pulmonary adenocarcinoma with osseous metaplasia: a rare occurrence possibly associated with early stage?

Zhang Q, Yin L, Li B, Meng R, Dao R, Hu S, Qiu X

OncoTargets and Therapy 2013, 6:1631-1634

Published Date: 11 November 2013

Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma

Peng HH, Zhang YD, Gong LS, Liu WD, Zhang Y

OncoTargets and Therapy 2013, 6:1625-1630

Published Date: 11 November 2013

Profile of panobinostat and its potential for treatment in solid tumors: an update

Anne M, Sammartino D, Barginear MF, Budman D

OncoTargets and Therapy 2013, 6:1613-1624

Published Date: 15 November 2013

Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification

Shimada Y, Saji H, Nomura M, Matsubayashi J, Yoshida K, Kakihana M, Kajiwara N, Ohira T, Ikeda N

OncoTargets and Therapy 2013, 6:1597-1604

Published Date: 8 November 2013

Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial

Liang J, E M, Wu G, Zhao L, Li X, Xiu X, Li N, Chen B, Hui Z, Lv J, Fang H, Tang Y, Bi N, Wang W, Zhai Y, Li T, Chen D, Zou SM, Lu N, Perez-Rodríguez R, Zheng J, Wang L

OncoTargets and Therapy 2013, 6:1589-1596

Published Date: 6 November 2013

Transcatheter arterial embolization promotes liver tumor metastasis by increasing the population of circulating tumor cells

Fang ZT, Wang GZ, Zhang W, Qu XD, Liu R, Qian S, Zhu L, Zhou B, Wang JH

OncoTargets and Therapy 2013, 6:1563-1572

Published Date: 5 November 2013

Successful treatment of paraganglioma with sorafenib: a case report and brief review of the literature

Lin Y, Li Q, Huang W, Jia X, Jiang H, Gao Y, Li Q

OncoTargets and Therapy 2013, 6:1559-1562

Published Date: 5 November 2013

Diagnostic efficacy of computed tomography-guided transthoracic needle aspiration and biopsy in patients with pulmonary disease

Tuna T, Ozkaya S, Dirican A, Findik S, Atici AG, Erkan L

OncoTargets and Therapy 2013, 6:1553-1557

Published Date: 5 November 2013

New and emerging treatment options for biliary tract cancer

Noel MS, Hezel AF

OncoTargets and Therapy 2013, 6:1545-1552

Published Date: 30 October 2013

Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients

He L, Peng K, Liu Y, Xiong J, Zhu FF

OncoTargets and Therapy 2013, 6:1539-1543

Published Date: 30 October 2013

Focus on treatment of lung carcinoid tumor

Noel-Savina E, Descourt R

OncoTargets and Therapy 2013, 6:1533-1537

Published Date: 25 October 2013

Comparative research on the efficacy of CyberKnife® and surgical excision for Stage I hepatocellular carcinoma

Yuan Z, Tian L, Wang P, Song Y, Dong Y, Zhuang H

OncoTargets and Therapy 2013, 6:1527-1532

Published Date: 29 October 2013

Isolated epithelioid trophoblastic tumor of the vagina: a case report and review of the literature

Zhao J, Xiang Y, Zhao D, Ren T, Feng F, Wan X

OncoTargets and Therapy 2013, 6:1523-1526

Published Date: 29 October 2013

Endometrial carcinoma with yolk sac tumor-like differentiation and elevated serum ß-hCG: a case report and literature review

Ji M, Lu Y, Guo L, Feng F, Wan X, Xiang Y

OncoTargets and Therapy 2013, 6:1515-1522

Published Date: 24 October 2013

Ductal adenocarcinoma of the prostate: immunohistochemical findings and clinical significance

Sha JJ, Bo JJ, Pan JH, Zhang LH, Xuan HQ, Chen W, Li D, Wang ZL, Liu DM, Huang YR

OncoTargets and Therapy 2013, 6:1501-1506

Published Date: 24 October 2013

The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis

Zarogoulidis K, Boutsikou E, Zarogoulidis P, Darwiche K, Freitag L, Porpodis K, Latsios D, Kontakiotis T, Huang H, Li Q, Hohenforst-Schmidt W, Kipourou M, Turner JF, Spyratos D

OncoTargets and Therapy 2013, 6:1493-1500

Published Date: 22 October 2013

Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC

Wu X, Liang WH, Hou X, Lin Z, Zhao HY, Huang Y, Fang WF, Zhao YY, Wu JX, Yang YP, Xue C, Hu ZH, Zhang J, Zhang JW, Ma YX, Zhou T, Qin T, Zhang L

OncoTargets and Therapy 2013, 6:1481-1491

Published Date: 21 October 2013

Epigenomic analysis of lung adenocarcinoma reveals novel DNA methylation patterns associated with smoking

Tan Q, Wang G, Huang J, Ding ZP, Luo QQ, Mok T, Tao Q, Lu S

OncoTargets and Therapy 2013, 6:1471-1479

Published Date: 21 October 2013

Survivin – biology and potential as a therapeutic target in oncology

Cheung CHA, Huang CC, Tsai FY, Lee JYC, Cheng SM, Chang YC, Huang YC, Chen SH, Chang JY

OncoTargets and Therapy 2013, 6:1453-1462

Published Date: 16 October 2013

VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody

Fushida S, Oyama K, Kinoshita J, Yagi Y, Okamoto K, Tajima H, Ninomiya I, Fujimura T, Ohta T

OncoTargets and Therapy 2013, 6:1445-1451

Published Date: 16 October 2013

Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer

Wang Z, Wang Z, Liang Z, Liu J, Shi W, Bai P, Lin X, Magaye R, Zhao J

OncoTargets and Therapy 2013, 6:1437-1444

Published Date: 16 October 2013

Targeting hedgehog signaling in cancer: research and clinical developments

Xie J, Bartels CM, Barton SW, Gu D

OncoTargets and Therapy 2013, 6:1425-1435

Published Date: 10 October 2013

Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis

Inokawa Y, Nomoto S, Hishida M, Hayashi M, Kanda M, Nishikawa Y, Takeda S, Fujiwara M, Koike M, Sugimoto H, Fujii T, Nakayama G, Yamada S, Tanaka C, Kobayashi D, Kodera Y

OncoTargets and Therapy 2013, 6:1417-1424

Published Date: 9 October 2013

The emerging and diverse roles of sirtuins in cancer: a clinical perspective

Yuan H, Su L, Chen WY

OncoTargets and Therapy 2013, 6:1399-1416

Published Date: 8 October 2013

Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer

Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K

OncoTargets and Therapy 2013, 6:1393-1398

Published Date: 7 October 2013

AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines

Leal P, Garcia P, Sandoval A, Buchegger K, Weber H, Tapia O, Roa JC

OncoTargets and Therapy 2013, 6:1373-1384

Published Date: 3 October 2013

Personalized treatment strategies in glioblastoma: MGMT promoter methylation status

Thon N, Kreth S, Kreth FW

OncoTargets and Therapy 2013, 6:1363-1372

Published Date: 27 September 2013

Emerging targets in cancer management: role of the CXCL12/CXCR4 axis

Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, Dubrovska A

OncoTargets and Therapy 2013, 6:1347-1361

Published Date: 30 September 2013

The relationship between Lin28 and the chemotherapy response of gastric cancer

Teng RY, Zhou JC, Jiang ZN, Xu CY, Li ZD, Wang QC, Xu CP, Guo JF, Shen JG, Wang LB

OncoTargets and Therapy 2013, 6:1341-1345

Published Date: 24 September 2013

Double siRNA-targeting of cIAP2 and LIVIN results in synergetic sensitization of HCT-116 cells to oxaliplatin treatment

Bavykin AS, Korotaeva AA, Poyarkov SV, Syrtsev AV, Tjulandin SA, Karpukhin AV

OncoTargets and Therapy 2013, 6:1333-1340

Published Date: 23 September 2013

Estimation of the displacement of cardiac substructures and the motion of the coronary arteries using electrocardiographic gating

Tan W, Xu L, Wang X, Qiu D, Han G, Hu D

OncoTargets and Therapy 2013, 6:1325-1332

Published Date: 20 September 2013

Expression and prognostic relevance of MET and phospho-BAD in non-small cell lung cancer

Sun W, Ai T, Gao Y, Zhang Y, Cui J, Song L

OncoTargets and Therapy 2013, 6:1315-1323

Published Date: 18 September 2013

Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients

Tejerizo-García A, Jiménez-López JS, Muñoz-González JL, Bartolomé-Sotillos S, Marqueta-Marqués L, López-González G, Pérez-Regadera Gómez JF

OncoTargets and Therapy 2013, 6:1305-1313

Published Date: 16 September 2013

IAP proteins as targets for drug development in oncology

Dubrez L, Berthelet J, Glorian V

OncoTargets and Therapy 2013, 6:1285-1304

Published Date: 16 September 2013

Impact of age on functional exercise correlates in patients with advanced lung cancer

Wang LY, Wu HD, Chen KY, Hsieh CH, Lai CC

OncoTargets and Therapy 2013, 6:1277-1283

Published Date: 16 September 2013

Resveratrol decreases B-cell lymphoma-2 expression and viability in GH3 pituitary adenoma cells of the rat

Voellger B, Kirches E, Wilisch-Neumann A, Weise A, Tapia-Perez JH, Rupa R, Mawrin C, Firsching R

OncoTargets and Therapy 2013, 6:1269-1276

Published Date: 16 September 2013

Emerging targets in pancreatic cancer: epithelial–mesenchymal transition and cancer stem cells

Castellanos JA, Merchant NB, Nagathihalli NS

OncoTargets and Therapy 2013, 6:1261-1267

Published Date: 13 September 2013

Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition

Espinoza I, Pochampally R, Xing F, Watabe K, Miele L

OncoTargets and Therapy 2013, 6:1249-1259

Published Date: 6 September 2013

How to detour Treg cells in T cell-based antitumor immune therapy

Zheng S, Shen Y, Song Y, Yuan Y

OncoTargets and Therapy 2013, 6:1243-1247

Published Date: 6 September 2013

The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer

Denaro N, Lo Nigro C, Russi EG, Merlano MC

OncoTargets and Therapy 2013, 6:1231-1241

Published Date: 16 September 2013

Targeting cancer stem cells: emerging role of Nanog transcription factor

Wang ML, Chiou SH, Wu CW

OncoTargets and Therapy 2013, 6:1207-1220

Published Date: 4 September 2013

Lumbar paravertebral blockade as intractable pain management method in palliative care

Zaporowska-Stachowiak I, Kotlinska-Lemieszek A, Kowalski G, Kosicka K, Hoffmann K, Główka F, Łuczak J

OncoTargets and Therapy 2013, 6:1187-1196

Published Date: 3 September 2013

Clinical outcome of primary small cell carcinoma of the urinary bladder

Hou CP, Lin YH, Chen CL, Chang PL, Tsui KH

OncoTargets and Therapy 2013, 6:1179-1185

Published Date: 26 August 2013

Role of microRNAs in hepatocellular carcinoma: a clinical perspective

Callegari E, Elamin BK, Sabbioni S, Gramantieri L, Negrini M

OncoTargets and Therapy 2013, 6:1167-1178

Published Date: 2 September 2013

MicroRNA-205 downregulates mixed-lineage-AF4 oncogene expression in acute lymphoblastic leukemia

Dou L, Li J, Zheng D, Li Y, Gao X, Xu C, Gao L, Wang L, Yu L

OncoTargets and Therapy 2013, 6:1153-1160

Published Date: 26 August 2013

Significance of preoperative C-reactive protein as a parameter in patients with small cell carcinoma of the esophagus

Feng JF, Zhao HG, Liu JS, Chen QX

OncoTargets and Therapy 2013, 6:1147-1151

Published Date: 22 August 2013

Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli

Han JB, Sang F, Chang JJ, Hua YQ, Shi WD, Tang LH, Liu LM

OncoTargets and Therapy 2013, 6:1129-1138

Published Date: 19 August 2013

Potential of ponatinib to treat chronic myeloid leukemia and acute lymphoblastic leukemia

Price KE, Saleem N, Lee G, Steinberg M

OncoTargets and Therapy 2013, 6:1111-1118

Published Date: 20 August 2013

Combining molecular targeted agents with radiation therapy for malignant gliomas

Scaringi C, Enrici RM, Minniti G

OncoTargets and Therapy 2013, 6:1079-1095

Published Date: 9 August 2013

Adjuvant chemotherapy for luminal A breast cancer: a prospective study comparing two popular chemotherapy regimens

Kader YA, El-Nahas T, Sakr A

OncoTargets and Therapy 2013, 6:1073-1077

Published Date: 9 August 2013

Human epidermal growth factor receptor-2 overexpression and amplification in metastatic and recurrent high grade or type 2 endometrial carcinomas

Kato R, Hasegawa K, Ishii R, Owaki A, Torii Y, Oe S, Hirasawa H, Kobayashi Y, Udagawa Y

OncoTargets and Therapy 2013, 6:1065-1071

Published Date: 7 August 2013

454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples

Altimari A, de Biase D, De Maglio G, Gruppioni E, Capizzi E, Degiovanni A, D'Errico A, Pession A, Pizzolitto S, Fiorentino M, Tallini G

OncoTargets and Therapy 2013, 6:1057-1064

Published Date: 5 August 2013

Activation of the sonic hedgehog signaling pathway occurs in the CD133 positive cells of mouse liver cancer Hepa 1–6 cells

Jeng KS, Sheen IS, Jeng WJ, Yu MC, Hsiau HI, Chang FY, Tsai HH

OncoTargets and Therapy 2013, 6:1047-1055

Published Date: 5 August 2013

Update on oncolytic viral therapy – targeting angiogenesis

Tysome JR, Lemoine NR, Wang Y

OncoTargets and Therapy 2013, 6:1031-1040

Published Date: 31 July 2013

Update on imatinib for gastrointestinal stromal tumors: duration of treatment

Linch M, Claus J, Benson C

OncoTargets and Therapy 2013, 6:1011-1023

Published Date: 30 July 2013

Critical analysis of the potential for targeting STAT3 in human malignancy

Peyser ND, Grandis JR

OncoTargets and Therapy 2013, 6:999-1010

Published Date: 30 July 2013

Cordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cells

Chen YH, Wang JY, Pan BS, Mu YF, Lai MS, So EC, Wong TS, Huang BM

OncoTargets and Therapy 2013, 6:983-998

Published Date: 25 July 2013

The role of fluorescence diagnosis in clinical practice

Sieroń A, Sieroń-Stołtny K, Kawczyk-Krupka A, Latos W, Kwiatek S, Straszak D, Bugaj AM

OncoTargets and Therapy 2013, 6:977-982

Published Date: 24 July 2013

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system

Rokita M, Stec R, Bodnar L, Charkiewicz R, Korniluk J, Smoter M, Cichowicz M, Chyczewski L, Nikliński J, Kozłowski W, Szczylik C

OncoTargets and Therapy 2013, 6:967-976

Published Date: 24 July 2013

Gamma secretase inhibitors of Notch signaling

Olsauskas-Kuprys R, Zlobin A, Osipo C

OncoTargets and Therapy 2013, 6:943-955

Published Date: 23 July 2013

Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer

Xu R, Ma N, Wang F, Ma L, Chen R, Chen R, Kebinu M, Ma LL, Han ZC, Ayixiamu, Mayier M, Su PC, Naman YM, Jieensi H, Yang HX, Adili A, Aili S, Liu J

OncoTargets and Therapy 2013, 6:925-929

Published Date: 25 July 2013

Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer

Zhang Y, Hu J, Li J, Wang N, Li W, Zhou Y, Liu J, Wei L, Shi M, Wang S, Wang J, Li X, Ma W

OncoTargets and Therapy 2013, 6:917-923

Published Date: 19 July 2013

Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AX

Takatori E, Shoji T, Sawai T, Kurose A, Sugiyama T

OncoTargets and Therapy 2013, 6:901-907

Published Date: 17 July 2013

Current status of bevacizumab in advanced ovarian cancer

Tomao F, Papa A, Rossi L, Caruso D, Benedetti Panici P, Venezia M, Tomao S

OncoTargets and Therapy 2013, 6:889-899

Published Date: 22 July 2013

Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer

Luo RZ, Yuan ZY, Li M, Xi SY, Fu J, He J

OncoTargets and Therapy 2013, 6:883-888

Published Date: 19 July 2013

A miR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancer

Ding C, Li C, Wang H, Li B, Guo Z

OncoTargets and Therapy 2013, 6:877-881

Published Date: 11 July 2013

Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors

Li ZY, Zhang XH, Chen Y, Guo JG, Sai K, Yang QY, Chen ZP, Mou YG

OncoTargets and Therapy 2013, 6:869-875

Published Date: 10 July 2013

Combined use of cyclophosphamide and Chalone 19-peptide in experimental breast cancer

Huang Y, He Y, Ye S, Li X, Zhong Q, Chen Z, Jin X

OncoTargets and Therapy 2013, 6:861-867

Published Date: 10 July 2013

Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer

Maric G, Rose AA, Annis MG, Siegel PM

OncoTargets and Therapy 2013, 6:839-852

Published Date: 9 July 2013

Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology

González-Masiá JA, García-Olmo D, García-Olmo DC

OncoTargets and Therapy 2013, 6:819-832

Published Date: 8 July 2013

Long term results of sentinel lymph node biopsy in early oral squamous cell carcinoma

Dequanter D, Shahla M, Paulus P, Lothaire P

OncoTargets and Therapy 2013, 6:799-802

Published Date: 25 June 2013

Potential use of custirsen to treat prostate cancer

Higano CS

OncoTargets and Therapy 2013, 6:785-797

Published Date: 25 June 2013

Apoptosis and G2/M arrest induced by Allium ursinum (ramson) watery extract in an AGS gastric cancer cell line

Xu XY, Song GQ, Yu YQ, Ma HY, Ma L, Jin YN

OncoTargets and Therapy 2013, 6:779-783

Published Date: 25 June 2013

Drugs for solid cancer the productivity crisis prompts a rethink

Rosel D, Brabek J, Vesely P, Fernandes M

OncoTargets and Therapy 2013, 6:767-777

Published Date: 26 June 2013

Efficacy of intraarterial chemoinfusion therapy for locally advanced breast cancer patients: a retrospective analysis of 28 cases

Zhang W, Liu R, Wang YY, Qian S, Wang JH, Yan ZP, Zhang HW

OncoTargets and Therapy 2013, 6:761-765

Published Date: 25 June 2013

Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma

Yoo EJ, Shin HS, Kim SU, Joo DJ, Park JY, Choi GH, Kim DY, Ahn SH, Seong J, Koh MJ, Han KH, Chon CY

OncoTargets and Therapy 2013, 6:755-759

Published Date: 21 June 2013

Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia

Cross M, Bach E, Tran T, Krahl R, Jaekel N, Niederwieser D, Junghanss C, Maschmeyer G, Al-Ali HK

OncoTargets and Therapy 2013, 6:741-748

Published Date: 20 June 2013

Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors

Zhang Z, Hao C, Wang L, Liu P, Zhao L, Zhu C, Tian X

OncoTargets and Therapy 2013, 6:733-740

Published Date: 18 June 2013

Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcoma

Sonaglio V, de Carvalho AC, Toledo SRC, Salinas-Souza C, Carvalho AL, Petrilli AS, de Camargo B, Vettore AL

OncoTargets and Therapy 2013, 6:713-723

Published Date: 17 June 2013

Primary primitive neuroectodermal tumor of the cervix

Li B, Ouyang L, Han X, Zhou Y, Tong X, Zhang S, Zhang Q

OncoTargets and Therapy 2013, 6:707-711

Published Date: 17 June 2013

Fatal bleeding in a nasopharyngeal carcinoma patient after concurrent chemoradiation plus cetuximab: a case report

Zheng LY, Yan SX, Yan DF, Yang JS, Wang YX

OncoTargets and Therapy 2013, 6:703-706

Published Date: 13 June 2013

Cyclin D1 affects epithelial–mesenchymal transition in epithelial ovarian cancer stem cell-like cells

Jiao J, Huang L, Ye F, Shi MF, Cheng XD, Wang XY, Hu DX, Xie X, Lu WG

OncoTargets and Therapy 2013, 6:667-677

Published Date: 20 June 2013

Long-term results of a randomized controlled trial evaluating preoperative chemotherapy in resectable non-small cell lung cancer

Chen ZW, Luo QQ, Jian H, Zhou Z, Cheng BJ, Lu S, Liao ML

OncoTargets and Therapy 2013, 6:645-650

Published Date: 7 June 2013

Current management options for recurrent adrenocortical carcinoma

Glover AR, Ip JCY, Zhao JT, Soon PSH, Robinson BG, Sidhu SB

OncoTargets and Therapy 2013, 6:635-643

Published Date: 6 June 2013

Nanomaterials in the application of tumor vaccines: advantages and disadvantages

Li XD, Gao JY, Yang Y, Fang HY, Han YJ, Wang XM, Ge W

OncoTargets and Therapy 2013, 6:629-634

Published Date: 5 June 2013

Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma

Özün Özbay P, Ekinci T, Yiğit S, Yavuzcan A, Uysal S, Soylu F, Cakalogaoglu F

OncoTargets and Therapy 2013, 6:621-627

Published Date: 7 June 2013

Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today

Kallianos A, Tsimpoukis S, Zarogoulidis P, Darwiche K, Charpidou A, Tsioulis I, Trakada G, Porpodis K, Spyratos D, Panoutspoulos A, Veletza L, Kostopoulos K, Kostopoulos C, Karapantzos I, Tsakiridis K, Hohenforst-Schmidt W, Zarogoulidis K, Rapti A, Syrigos K

OncoTargets and Therapy 2013, 6:609-613

Published Date: 31 May 2013

 Telangiectatic osteosarcoma: a review of literature

Liu J, Liu S, Wang J, Zhu W, Hua Y, Sun W, Cai Z

OncoTargets and Therapy 2013, 6:593-602

Published Date: 28 May 2013

Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma

Luo J, Chen M, Huang H, Yan T, Zhang M, Zhang K, Deng S

OncoTargets and Therapy 2013, 6:577-583

Published Date: 22 May 2013

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer

Berardi R, Santoni M, Morgese F, Ballatore Z, Savini A, Onofri A, Mazzanti P, Pistelli M, Pierantoni C, De Lisa M, Caramanti M, Pagliaretta S, Pellei C, Cascinu S

OncoTargets and Therapy 2013, 6:563-576

Published Date: 21 May 2013

Abundance of Flt3 and its ligand in astrocytic tumors

Eßbach C, Andrae N, Pachow D, Warnke JP, Wilisch-Neumann A, Kirches E, Mawrin C

OncoTargets and Therapy 2013, 6:555-561

Published Date: 24 May 2013

Dose-effect relationship of CpG oligodeoxyribonucleotide 1826 in murine Lewis lung cancer treated with irradiation

Zhuang XB, Qiao TK, Yuan SJ, Chen W, Zha L, Yan L

OncoTargets and Therapy 2013, 6:549-554

Published Date: 20 May 2013

New dilemmas in small-cell lung cancer TNM clinical staging

Zarogoulidis K, Latsios D, Porpodis K, Zarogoulidis P, Darwiche K, Antoniou N, Hohenforst-Schmidt W, Eleftheriadou E, Boutsikou E, Kontakiotis T

OncoTargets and Therapy 2013, 6:539-547

Published Date: 16 May 2013

Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma

Terpos E, Kanellias N, Christoulas D, Kastritis E, Dimopoulos MA

OncoTargets and Therapy 2013, 6:531-538

Published Date: 10 May 2013

Type 1 insulin-like growth factor receptor monoclonal antibody (HX-1162) treatment for liver cancer

Chen XH, Li ZQ, Peng H, Jin SM, Fu HQ, Zhu TC, Weng XG

OncoTargets and Therapy 2013, 6:527-530

Published Date: 14 May 2013

Interleukin-12 prevents colorectal cancer liver metastases in mice

Shen F, Li JL, Cai WS, Zhu GH, Gu WL, Jia L, Xu B

OncoTargets and Therapy 2013, 6:523-526

Published Date: 13 May 2013

Antitumor effects and mechanisms of dendritic cells stimulated by sCD40L on ovarian cancer cells in vitro

Zhang ZM, Yang XM, Zhang C, Zhang MJ, Li X, Zhang FH, Kang S, Wang SJ, Shan BE

OncoTargets and Therapy 2013, 6:503-515

Published Date: 6 May 2013

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma

Zhang L, Shi L, Zhao X, Wang Y, Yue W

OncoTargets and Therapy 2013, 6:497-502

Published Date: 7 May 2013

Treatment outcome of advanced pancreatic cancer patients who are ineligible for a clinical trial

Ueda A, Hosokawa A, Ogawa K, Yoshita H, Ando T, Kajiura S, Fujinami H, Kawai K, Nishikawa J, Tajiri K, Minemura M, Sugiyama T

OncoTargets and Therapy 2013, 6:491-496

Published Date: 8 May 2013

Effect and safety of bevacizumab-containing chemotherapy treatment in Chinese patients with metastatic colorectal cancer

Wu Q, Shi Y, Chen L, Xiao XY, Dai GH

OncoTargets and Therapy 2013, 6:485-490

Published Date: 30 April 2013

A review of the use of somatostatin analogs in oncology

Keskin O, Yalcin S

OncoTargets and Therapy 2013, 6:471-483

Published Date: 26 April 2013

Candidate cancer-targeting agents identified by expression-profiling arrays

Termglinchan V, Wanichnopparat W, Suwanwongse K, Teeyapant C, Chatpermporn K, Leerunyakul K, Chuadpia K, Sirimaneethum O, Wijitworawong P, Mutirangura W, Aporntewan C, Vinayanuwattikun C, Mutirangura A

OncoTargets and Therapy 2013, 6:447-458

Published Date: 23 April 2013

Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment

Rachmut IH, Samuels N, Melnick SJ, Ramachandran C, Sharabi Y, Pavlovsky A, Maimon Y, Shoham J

OncoTargets and Therapy 2013, 6:437-445

Published Date: 24 April 2013

RUNX3 gene promoter demethylation by 5-Aza-CdR induces apoptosis in breast cancer MCF-7 cell line

Kang HF, Dai ZJ, Bai HP, Lu WF, Ma XB, Bao X, Lin S, Wang XJ

OncoTargets and Therapy 2013, 6:411-417

Published Date: 17 April 2013

Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21)

Amini A, Ehteda A, Masoumi Moghaddam S, Akhter J, Pillai K, Morris DL

OncoTargets and Therapy 2013, 6:403-409

Published Date: 16 April 2013

An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer

Rick FG, Block NL, Schally AV

OncoTargets and Therapy 2013, 6:391-402

Published Date: 16 April 2013

Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges

Rahmathulla G, Hovey EJ, Hashemi-Sadraei N, Ahluwalia MS

OncoTargets and Therapy 2013, 6:371-389

Published Date: 15 April 2013

Laparoscopic partial nephrectomy of thyroid cancer metastasis: case report and review of the literature

Cochetti G, Puxeddu E, Del Zingaro M, D’Amico F, Cottini E, Barillaro F, Mearini E

OncoTargets and Therapy 2013, 6:355-360

Published Date: 10 April 2013

MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B

Yu XY, Zhang Z, Liu J, Zhan B, Kong CZ

OncoTargets and Therapy 2013, 6:349-354

Published Date: 10 April 2013

HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients

Qin T, Yuan Z, Peng R, Bai B, Shi Y, Teng X, Liu D, Wang S

OncoTargets and Therapy 2013, 6:341-347

Published Date: 9 April 2013

A feasibility study of NIR fluorescent image-guided surgery in head and neck cancer based on the assessment of optimum surgical time as revealed through dynamic imaging

Yokoyama J, Fujimaki M, Ohba S, Anzai A, Yoshii R, Ito S, Kojima M, Ikeda K

OncoTargets and Therapy 2013, 6:325-330

Published Date: 8 April 2013

Update of research on the role of EZH2 in cancer progression

Shen L, Cui J, Liang S, Pang Y, Liu P

OncoTargets and Therapy 2013, 6:321-324

Published Date: 4 April 2013

Primary malignant fibrous histiocytoma of the breast: report of one case

Liu C, Zhao Z, Zhang Q, Wu Y, Jin F

OncoTargets and Therapy 2013, 6:315-319

Published Date: 3 April 2013

Application of quantum dots as vectors in targeted survivin gene siRNA delivery

Zhao JJ, Qiu XL, Wang ZP, Pan J, Chen J, Han JS

OncoTargets and Therapy 2013, 6:303-309

Published Date: 3 April 2013

Treatment results of incomplete chemoradiotherapy in locally advanced cervical cancer

Gao Y, Gao F, Liu Z, Song LP

OncoTargets and Therapy 2013, 6:297-302

Published Date: 2 April 2013

Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma

Wang Z, Zhang H, He L, Dong W, Li J, Shan Z, Teng W

OncoTargets and Therapy 2013, 6:281-287

Published Date: 28 March 2013

Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer

Dong X, Yang M, Sun H, Lü J, Zheng Z, Li Z, Zhong L

OncoTargets and Therapy 2013, 6:273-279

Published Date: 28 March 2013

Surgery in asymptomatic patients with colorectal cancer and unresectable liver metastases: the authors' experience

Boselli C, Renzi C, Gemini A, Castellani E, Trastulli S, Desiderio J, Corsi A, Barberini F, Cirocchi R, Santoro A, Parisi A, Redler A, Noya G

OncoTargets and Therapy 2013, 6:267-272

Published Date: 27 March 2013

Systematic review of dasatinib in chronic myeloid leukemia

Breccia M, Salaroli A, Molica M, Alimena G

OncoTargets and Therapy 2013, 6:257-265

Published Date: 27 March 2013

Antitumor effects of inductive hyperthermia using magnetic ferucarbotran nanoparticles on human lung cancer xenografts in nude mice

Araya T, Kasahara K, Nishikawa S, Kimura H, Sone T, Nagae H, Ikehata Y, Nagano I, Fujimura M

OncoTargets and Therapy 2013, 6:237-242

Published Date: 24 March 2013

Syringocystadenoma papilliferum in the right lower abdomen: a case report and review of literature

Xu D, Bi T, Lan H, Yu W, Wang W, Cao F, Jin K

OncoTargets and Therapy 2013, 6:233-236

Published Date: 26 March 2013

Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib

Rajendra R, Jones RL, Pollack SM

OncoTargets and Therapy 2013, 6:217-222

Published Date: 18 March 2013

Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation

Duan Y, Zhao X, Ren W, Wang X, Yu KF, Li D, Zhang X, Zhang Q

OncoTargets and Therapy 2013, 6:189-198

Published Date: 14 March 2013

Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance

Zhao C, Chen Y, Zhang W, Zhang J, Xu Y, Li W, Chen S, Deng A

OncoTargets and Therapy 2013, 6:183-188

Published Date: 8 March 2013

3´ untranslated region 1630 C>T polymorphism of prohibitin increases risk of breast cancer

Tang L, Zhao Y, Nie W, Wang Z, Guan X

OncoTargets and Therapy 2013, 6:177-182

Published Date: 9 March 2013

Novel Bruton's tyrosine kinase inhibitors currently in development

D'Cruz OJ, Uckun FM

OncoTargets and Therapy 2013, 6:161-176

Published Date: 6 March 2013

Docetaxel for non small cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation

Yamane H, Ochi N, Yasugi M, Tabayashi T, Yamagishi T, Monobe Y, Hisamoto A, Kiura K, Takigawa N

OncoTargets and Therapy 2013, 6:155-160

Published Date: 6 March 2013

Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling

Jin H, Gong W, Zhang C, Wang S

OncoTargets and Therapy 2013, 6:145-153

Published Date: 8 March 2013

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC

Nelson V, Ziehr J, Agulnik M, Johnson M

OncoTargets and Therapy 2013, 6:135-143

Published Date: 5 March 2013

Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer

Boutsikou E, Kontakiotis T, Zarogoulidis P, Darwiche K, Eleptheriadou E, Porpodis K, Galaktidou G, Sakkas L, Hohenforst-Schmidt W, Tsakiridis K, Karaiskos T, Zarogoulidis K

OncoTargets and Therapy 2013, 6:125-134

Published Date: 1 March 2013

Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia

Keller-von Amsberg G, Koschmieder S

OncoTargets and Therapy 2013, 6:99-106

Published Date: 4 March 2013

Molecular guided therapy for advanced pancreatic cancer patients with PI3K activated mutation: vision or illusion?

Gazzah A, Gonzales DB, Levy A, Bahleda R, Ducreux M, Lacroix L, Soria JC

OncoTargets and Therapy 2013, 6:95-97

Published Date: 20 February 2013

Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer

Hamizi S, Freyer G, Bakrin N, Henin E, Mohtaram A, Le Saux O, Falandry C

OncoTargets and Therapy 2013, 6:89-94

Published Date: 14 February 2013

The feasibility of a fiber optic laser approach to relieving lymphedematous syndrome: a case report

Palmieri B, Di Cerbo A, Rottigni V, Fistetto G, Iannitti T

OncoTargets and Therapy 2013, 6:85-88

Published Date: 11 February 2013

Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells

Alarifi S, Ali D, Alkahtani S, Siddiqui MA, Ali BA

OncoTargets and Therapy 2013, 6:75-84

Published Date: 7 February 2013

Clinical outcome observation of preoperative concurrent chemoradiotherapy/radiotherapy alone in 174 Chinese patients with local advanced cervical carcinoma

Wei LC, Wang N, Shi M, Liu JY, Li JP, Zhang Y, Huang YH, Li X, Chen Y

OncoTargets and Therapy 2013, 6:67-74

Published Date: 7 February 2013

Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients – a preliminary result

Hsieh CH, Tien HJ, Hsiao SM, Wei MC, Wu WY, Sun HD, Wang LY, Hsieh YP, Chen YJ, Shueng PW

OncoTargets and Therapy 2013, 6:59-66

Published Date: 4 February 2013

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer

Geva R, Vecchione L, Tejpar S, Piessevaux H, Van Cutsem E, Prenen H

OncoTargets and Therapy 2013, 6:53-58

Published Date: 25 January 2013

Learning curve for endoscopic thyroidectomy: a single teaching hospital study

Cao F, Jin K, Cui B, Xie B

OncoTargets and Therapy 2013, 6:47-52

Published Date: 23 January 2013

Circadian rhythm characteristics of oral squamous cell carcinoma growth in an orthotopic xenograft model

Zhao NB, Tang H, Yang K, Chen D

OncoTargets and Therapy 2013, 6:41-46

Published Date: 23 January 2013

Dendritic cells fused with different pancreatic carcinoma cells induce different T-cell responses

Andoh Y, Makino N, Yamakawa M

OncoTargets and Therapy 2013, 6:29-40

Published Date: 22 January 2013

Pseudomembranous colitis within radiotherapy field following concurrent chemoradiation therapy: a case report

Shen BJ, Lin SC, Shueng PW, Chou YH, Tseng LM, Hsieh CH

OncoTargets and Therapy 2013, 6:25-28

Published Date: 17 January 2013